Sort
30,917 grants matching “tumor microenvironment”
Core C: High Dimensional Cellular and Spatial Analysis
$658,874Evan Newell · Fred Hutchinson Cancer Center · P01 · FY2024 · CA
Collagen Signaling in Pancreatic Cancer
$658,784Howard C Crawford · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · CA
Remodeling Chromatin and the Tumor Microenvironment: Direct Oncogenesis and Therapeutic Targeting
$658,720David E Fisher · Massachusetts General Hospital · P01 · FY2024 · CA
Novel targeted therapy for treating Ovarian Cancer
$658,621Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2025 · CA
Dissecting the Kaposi Sarcoma Tumor Microenvironment at the Single Cell Level
$658,549Warren Phipps · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer
$658,454Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
$658,439Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2019 · CA
Engineering T Cell Adoptive Therapy for Glioblastoma
$658,407Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2023 · NS
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity
$658,369David G Denardo · Washington University · U01 · FY2023 · CA
Molecular Biomarkers in pathogenesis of Lymphangioleiomyomatosis (LAM)
$658,331Jeanine M D'armiento · Columbia University Health Sciences · R01 · FY2025 · HL
Type 2 immunity: a primitive response to epithelial injury that shapes bone marrow and lung myeloid crosstalk
$658,328Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Type 2 immunity: a primitive response to epithelial injury that shapes bone marrow and lung myeloid crosstalk
$658,328Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
$658,205Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
VPS72 controls Treg cell stability and adaptation to tumor microenvironment
$658,092Qing-Sheng Mi · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2023 · CA
Early response to radiotherapy and immunotherapy in rectal cancer: an integrated molecular, cellular, and spatial approach
$658,048Todd A Aguilera · Ut Southwestern Medical Center · R01 · FY2025 · CA
EFFECT OF CD47 ON THE TUMOR MICROENVIRONMENT IN DIFFUSE MIDLINE GLIOMA A FATAL PEDIATRIC BRAIN TUMOR
$658,000The Johns Hopkins University · · FY2025 · Defense Health Agency
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$657,955Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2019 · CA
DCE-MRI guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
$657,895Harrison Kim · Ohio State University · R01 · FY2025 · CA
Multi-cellular interactions defining the human brain metastatic niche
$657,805Benjamin Izar · Columbia University Health Sciences · R01 · FY2024 · CA
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation
$657,791Cheryl A London · Tufts University Boston · U01 · FY2023 · CA
"Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis"
$657,652Dawid Grzegorz Nowak · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Model-based Prediction of Redox-Modulated Responses to Cancer Treatments
$657,611Melissa Lambeth Kemp · Georgia Institute Of Technology · U01 · FY2017 · CA
Targeting head and neck cancer cells and the adverse tumor microenvironment with a novel small-molecule STAT3 inhibitor
$657,573David John Tweardy · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Role of FACT in ZFTA-RelA fusion driven ependymoma
$657,440Monica Venere · Ohio State University · R01 · FY2024 · CA
Using genetically engineered mouse models of brain tumors to develop therapeutic nanoparticles & biomaterials
$657,360Eric C Holland · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA